心肌康方案治疗急性期病毒性心肌炎

Xinjikang Program in Ntreatment of Syndrome of Acute Phase of Viral Yyocarditis

摘要:

目的: 观察心肌康方案对病毒性心肌炎急性期患者中医证候疗效的影响。 方法: 将在河南省中医院、黑龙江省中医研究院、上海中医药大学附属龙华医院就诊的161例符合纳入标准,且不符合排除标准的病毒性心肌炎急性期患者,随机分为治疗组和对照组。治疗组在基础措施上加用心肌康方案,对照组在基础措施上加用西药常规治疗。疗程30 d。观察并记录患者的中医证候,应用统计方法,分析心肌康方案的中医证候疗效。 结果: 两组证候等级疗效及总有效率比较、两组各个时点与本组治疗前证候总积分组内比较、两组治疗前与第30天证候总积分组内比较,差异均有统计学意义(P<0.05),两组证候总积分、证候总积分差值的组间比较,差异均有统计学意义(P<0.05)。 结论: 心肌康方案与西医常规治疗均能改善患者中医证候总积分,但心肌康方案在证候等级疗效及总有效率方面明显优于西医常规治疗。

Abstract:

Objective: To explore the impact of Xinjikang program on syndrome of the acute phase of viral myocarditis. Method: One hundred and sixty-one cases from Henan Chinese medical hospital, Heilongjiang Academy of traditional Chinese medicine(TCM), Shanghai University of TCM, Longhua Hospital three hospital, entered the study. Cases were randomly divided into treatment group and control group. The treatment group was treated by Xinjikang program plus basic treatment, control group was treated by conventional western medicine plus the basic measures. The course lasted for 30 days. The patient's syndromes were observed. Result: The difference of syndrome total score between the two groups was statistically significant (P<0.05). The difference of total score syndrome at various time point between the two groupswas statistically significant (P<0.05). The difference of total score syndrome before and after treatment was statistically significant (P<0.05). Conclusion: Xinjikang program and routine western medicine can improve the syndromes in patients with syndrome of the acute phase of viral myocarditis but efficiency of Xinjikang program was significantly superior to conventional western treatment.